GT199900180AA - PHARMACEUTICAL COMPOSITION TO BE APPLIED TO MUCOSES. - Google Patents
PHARMACEUTICAL COMPOSITION TO BE APPLIED TO MUCOSES.Info
- Publication number
- GT199900180AA GT199900180AA GT199900180AK GT199900180K GT199900180AA GT 199900180A A GT199900180A A GT 199900180AA GT 199900180A K GT199900180A K GT 199900180AK GT 199900180 K GT199900180 K GT 199900180K GT 199900180A A GT199900180A A GT 199900180AA
- Authority
- GT
- Guatemala
- Prior art keywords
- mucoses
- pharmaceutical composition
- mucosa
- composition
- thanks
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 5
- 210000004877 mucosa Anatomy 0.000 abstract 3
- 229940126601 medicinal product Drugs 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000035699 permeability Effects 0.000 abstract 2
- XLYOFNOQVPJJNP-PWCQTSIFSA-N Tritiated water Chemical compound [3H]O[3H] XLYOFNOQVPJJNP-PWCQTSIFSA-N 0.000 abstract 1
- 229940030225 antihemorrhagics Drugs 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 238000002651 drug therapy Methods 0.000 abstract 1
- 239000002874 hemostatic agent Substances 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/22—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of calcitonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Abstract
LA PRESENTE INVENCIÓN PROVEE UNA COMPOSICIÓN FARMACÉUTICA PARA SER APLICADA A LAS MUCOSAS, A SER UTILIZADA EN LA TERAPIA CON DROGAS Y QUE COMPRENDE UNA SUSTANCIA NO SOLUBLE EN AGUA Y/O POCO SOLUBLE EN AGUA, UN MEDICAMENTO, Y UN MEDIO ACUOSO, Y QUE TIENE UNA PRESIÓN OSMÓTICA DE MENOS 290 MOSM. ESTA COMPOSICIÓN ES SUPERIOR A LAS COMPOSICIONES FARMACÉUTICAS CONVENCIONALES PARA SER APLICADAS SOBRE LAS MUCOSAS, GRACIAS A SU EFICIENTE Y ELEVADA PERMEABILIDAD A LA SANGRE, EN LUGAR DE LA MUCOSAA. LA PRESENTE INVENCIÓN PROVEE ADEMÁS UNA COMPOSICIÓN FARMACÉUTICA PARA SER APLICADA A LA MUCOSA, QUE COMPRENDE UNA AGENTE HEMOSTÁTICO Y UN MEDICAMENTO. ESTA COMPOSICÍÓN ES SUPERIOR A LAS COMPOSICIONES FARMACÉUTICAS CONVENCIONALES PARA SER APLICADAS A LA MUCOSA, GRACIAS A SU PERMEABILIDAD Y RETENCIÓN EN LA MUCOSA.THE PRESENT INVENTION PROVIDES A PHARMACEUTICAL COMPOSITION TO BE APPLIED TO MUCOSES, TO BE USED IN DRUG THERAPY AND UNDERSTANDING A SUBSTANCE NOT SOLUBLE IN WATER AND / OR LITTLE SOLUBLE IN WATER, A MEDICINAL PRODUCT, AND A MEDIUM MEDIA AN OSMOTE PRESSURE OF LESS 290 MOSM. THIS COMPOSITION IS SUPERIOR TO THE CONVENTIONAL PHARMACEUTICAL COMPOSITIONS TO BE APPLIED ON THE MUCOSES, THANKS TO ITS EFFICIENT AND ELEVATED BLOOD PERMEABILITY, INSTEAD OF THE MUCOSAA. THE PRESENT INVENTION ALSO PROVIDES A PHARMACEUTICAL COMPOSITION TO BE APPLIED TO THE MUCOSA, WHICH INCLUDES A HEMOSTATIC AGENT AND A MEDICINAL PRODUCT. THIS COMPOSITION IS SUPERIOR TO THE CONVENTIONAL PHARMACEUTICAL COMPOSITIONS TO BE APPLIED TO THE MUCOSA, THANKS TO ITS PERMEABILITY AND RETENTION IN THE MUCOSA.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11088798 | 1998-04-21 | ||
JP11088898 | 1998-04-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT199900180AA true GT199900180AA (en) | 2006-08-29 |
Family
ID=26450407
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT199900180A GT199900180A (en) | 1998-04-21 | 1999-10-19 | PHARMACEUTICAL COMPOSITION TO BE APPLIED TO MUCOSES. |
GT199900180AK GT199900180AA (en) | 1998-04-21 | 1999-10-19 | PHARMACEUTICAL COMPOSITION TO BE APPLIED TO MUCOSES. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT199900180A GT199900180A (en) | 1998-04-21 | 1999-10-19 | PHARMACEUTICAL COMPOSITION TO BE APPLIED TO MUCOSES. |
Country Status (36)
Country | Link |
---|---|
US (3) | US6939559B1 (en) |
EP (1) | EP0998916B1 (en) |
JP (2) | JP5142420B2 (en) |
KR (1) | KR100686901B1 (en) |
CN (1) | CN1304052C (en) |
AT (1) | ATE336986T1 (en) |
AU (1) | AU757772B2 (en) |
BG (1) | BG64919B1 (en) |
BR (1) | BRPI9906372B8 (en) |
CA (1) | CA2294457C (en) |
CY (1) | CY1105771T1 (en) |
CZ (1) | CZ298466B6 (en) |
DE (1) | DE69932905T2 (en) |
DK (1) | DK0998916T3 (en) |
EA (1) | EA002967B1 (en) |
EE (1) | EE05072B1 (en) |
ES (1) | ES2272064T3 (en) |
GE (1) | GEP20022669B (en) |
GT (2) | GT199900180A (en) |
HR (1) | HRP990402C1 (en) |
HU (1) | HU226712B1 (en) |
ID (1) | ID24818A (en) |
IL (1) | IL133614A (en) |
IS (1) | IS2453B (en) |
NO (1) | NO328270B1 (en) |
NZ (1) | NZ501950A (en) |
PL (1) | PL197875B1 (en) |
PT (1) | PT998916E (en) |
RS (1) | RS49764B (en) |
SI (1) | SI0998916T1 (en) |
SK (1) | SK286101B6 (en) |
TR (1) | TR199903193T1 (en) |
TW (1) | TWI243687B (en) |
UA (1) | UA77640C2 (en) |
WO (1) | WO1999053899A1 (en) |
ZA (1) | ZA997727B (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6261836B1 (en) * | 1996-10-01 | 2001-07-17 | Geron Corporation | Telomerase |
AR026072A1 (en) | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | PHARMACEUTICAL COMPOSITION CONTAINING CICLESONIDE FOR MUCOSA APPLICATION |
AR026073A1 (en) | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | PHARMACEUTICAL COMPOSITION AQUATIC CONTAINING CICLESONIDE |
ES2393864T3 (en) * | 2002-08-30 | 2012-12-28 | Nycomed Gmbh | The use of the association of ciclesonide and antihistamines for the treatment of allergic rhinitis |
WO2004052399A1 (en) * | 2002-12-10 | 2004-06-24 | Showa Yakuhin Kako Co., Ltd. | Composition for topical anesthesia |
PT1572217E (en) * | 2002-12-12 | 2008-11-28 | Nycomed Gmbh | Combination medicament of r,r-formoterol and ciclesonide |
US20050025825A1 (en) | 2003-07-31 | 2005-02-03 | Xanodyne Pharmacal, Inc. | Tranexamic acid formulations with reduced adverse effects |
PL1670482T5 (en) * | 2003-09-16 | 2022-10-03 | Covis Pharma Gmbh | Use of ciclesonide for the treatment of respiratory diseases |
PE20050941A1 (en) * | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | AQUEOUS CYCLESOUND SUSPENSIONS FOR MISTING |
JP4128521B2 (en) * | 2003-12-19 | 2008-07-30 | 信越化学工業株式会社 | Gel sheet and method for producing the same |
US20090215898A1 (en) | 2004-03-04 | 2009-08-27 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
US7947739B2 (en) | 2004-03-04 | 2011-05-24 | Ferring B.V. | Tranexamic acid formulations |
US20050244495A1 (en) | 2004-03-04 | 2005-11-03 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
US8022106B2 (en) | 2004-03-04 | 2011-09-20 | Ferring B.V. | Tranexamic acid formulations |
EP1740188A1 (en) * | 2004-04-20 | 2007-01-10 | Altana Pharma AG | Use of ciclesonide for the treatment of respiratory diseases in a smoking patient |
DE602005015506D1 (en) * | 2004-04-28 | 2009-09-03 | Shinetsu Chemical Co | Film preparation and process for its production |
US20070231396A1 (en) * | 2006-03-29 | 2007-10-04 | Ray Charles D | Medication spray formulation |
CA2717984C (en) * | 2008-03-14 | 2013-11-26 | Cephalon, Inc. | Enhanced transmucosal composition and dosage form |
PL2445472T3 (en) * | 2009-06-24 | 2018-07-31 | Lipoid Gmbh | Compositions for cosmetic, pharmaceutic or dietary applications |
WO2011135585A2 (en) | 2010-04-28 | 2011-11-03 | Cadila Healthcare Limited | Aqueous pharmaceutical solution of ciclesonide |
ES2951828T3 (en) | 2010-09-23 | 2023-10-25 | Leading Biosciences Inc | Administration of serine protease inhibitors to the stomach |
PL2661308T3 (en) | 2011-01-05 | 2019-10-31 | Prenatal Int Gmbh | Hypotonic aqueous composition with reduced chloride content, with or without phospholipids |
ES2375784B1 (en) | 2011-12-22 | 2013-01-24 | Laboratorios Kin S.A. | Tranexamic acid gel |
CN112641771B (en) | 2014-03-25 | 2022-04-15 | 恒翼生物医药科技(上海)有限公司 | Composition for treating autodigestion |
CN104473864B (en) * | 2014-11-25 | 2017-02-22 | 陈长潭 | Carbazochrome sodium sulfonate semisolid preparation and preparation method thereof |
RU2725664C2 (en) | 2015-10-30 | 2020-07-03 | Тейдзин Фарма Лимитед | Pharmaceutical composition for insertion into nasal mucosa |
US11666532B2 (en) | 2018-01-19 | 2023-06-06 | Hyloris Developments Sa | Tranexamic acid oral solution |
JPWO2022065404A1 (en) * | 2020-09-25 | 2022-03-31 | ||
EP4062919A1 (en) | 2021-03-24 | 2022-09-28 | Prenatal International GmbH | One or more compositions based on human amniotic fluid for use in a method of enteral nutrition, enteral nutritional supplementation and/or treatment and/or nutrition of low capillary layers |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4271143A (en) | 1978-01-25 | 1981-06-02 | Alcon Laboratories, Inc. | Sustained release ophthalmic drug dosage |
CH657779A5 (en) | 1982-10-05 | 1986-09-30 | Sandoz Ag | GALENIC COMPOSITIONS CONTAINING CALCITONIN. |
AU572815B2 (en) | 1982-12-29 | 1988-05-19 | Armour Pharmaceutical Company | Pharmaceutical calcitonin compositions for intranasal application |
JPS59163313A (en) * | 1983-03-09 | 1984-09-14 | Teijin Ltd | Peptide hormone composition for nasal administration |
GB8514090D0 (en) * | 1985-06-04 | 1985-07-10 | Sandoz Ltd | Organic compounds |
JPS6034925A (en) * | 1983-08-04 | 1985-02-22 | Mitsubishi Chem Ind Ltd | Preparation of 2-hydroxyisophthalaldehydes |
AU565354B2 (en) | 1983-11-14 | 1987-09-10 | Bio-Mimetics Inc. | Bioadhesive compositions and methods of treatment therewith |
JPS60123426A (en) * | 1983-12-07 | 1985-07-02 | Eisai Co Ltd | Secretin preparation for transnasal administration |
JPS60224616A (en) | 1984-04-24 | 1985-11-09 | Teijin Ltd | Composition for administration through nose |
US5179079A (en) | 1986-12-16 | 1993-01-12 | Novo Nordisk A/S | Nasal formulation and intranasal administration therewith |
NZ222907A (en) | 1986-12-16 | 1990-08-28 | Novo Industri As | Preparation for intranasal administration containing a phospholipid absorption enhancing system |
MY102411A (en) | 1986-12-23 | 1992-06-17 | Ciba Geigy Ag | Nasal solutions |
JPS63303031A (en) | 1987-05-30 | 1988-12-09 | Nippon Piston Ring Co Ltd | Vane for compressor |
JPS63303931A (en) * | 1987-06-05 | 1988-12-12 | Sumitomo Pharmaceut Co Ltd | Drug preparation for transnasal administration having growth hormone releasing activity |
PT88490B (en) * | 1987-09-14 | 1992-11-30 | Novo Nordisk As | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR TRANSOUCIDATING NON-ENTERPRISE LIBERATION CONTAINING MONOSCARARIDOS OR OLIGOSACARIDOS |
US5192535A (en) | 1988-02-08 | 1993-03-09 | Insite Vision Incorporated | Ophthalmic suspensions |
US5188826A (en) | 1988-02-08 | 1993-02-23 | Insite Vision Incorporated | Topical ophthalmic suspensions |
US5776493A (en) | 1989-07-14 | 1998-07-07 | Alza Corporation | Oral osmotic device for delivery of nystatin with hydrogel driving member |
ES2050096T3 (en) | 1989-10-31 | 1995-01-16 | Columbia Lab Inc | HUMIDIFYING COMPOSITION OF THE VAGINAL TISSUE. |
US5147654A (en) | 1990-07-23 | 1992-09-15 | Alza Corporation | Oral osmotic device for delivering nicotine |
JPH078806B2 (en) * | 1990-08-16 | 1995-02-01 | 旭化成工業株式会社 | Nasal emulsion containing calcitonin |
GB9102579D0 (en) | 1991-01-24 | 1991-03-27 | Glaxo Group Ltd | Compositions |
GB9103824D0 (en) | 1991-02-23 | 1991-04-10 | Fisons Ag | Formulation |
DE69233116T2 (en) | 1991-04-03 | 2004-08-26 | Keimowitz, Rudolph M.D., Wayzata | SUPPRESSION OF THE THROMBOX MIRROR BY PERCUTANEOUS ADMINISTRATION OF ASPIRIN |
US5200195A (en) | 1991-12-06 | 1993-04-06 | Alza Corporation | Process for improving dosage form delivery kinetics |
NZ245514A (en) * | 1991-12-27 | 1994-12-22 | Merck & Co Inc | Controlled release drug delivery device comprising a core and a polymeric coating which is water impermeable but contains apertures to expose the core |
CN1075081A (en) * | 1992-02-01 | 1993-08-11 | 解放军陆军第44医院 | The compound method of colloid anaesthetic compound |
GB9202519D0 (en) * | 1992-02-06 | 1992-03-25 | Glaxo Group Ltd | Medicaments |
JP3047948B2 (en) | 1992-12-07 | 2000-06-05 | 株式会社ツムラ | Composition for nasal administration of peptides |
US5340572A (en) | 1993-02-08 | 1994-08-23 | Insite Vision Incorporated | Alkaline ophthalmic suspensions |
US5409703A (en) | 1993-06-24 | 1995-04-25 | Carrington Laboratories, Inc. | Dried hydrogel from hydrophilic-hygroscopic polymer |
JP3781792B2 (en) | 1993-12-27 | 2006-05-31 | 千寿製薬株式会社 | Ophthalmic suspension containing difluprednate |
JPH07188059A (en) * | 1993-12-28 | 1995-07-25 | Rohto Pharmaceut Co Ltd | Therapeutic agent for periodontosis |
RU2102979C1 (en) | 1994-07-18 | 1998-01-27 | Панкрушева Татьяна Александровна | Agent for treatment of suppurative-inflammatory skin and mucous membrane process |
WO1997001337A1 (en) | 1995-06-29 | 1997-01-16 | Mcneil-Ppc, Inc. | The combination of topical nasal antihistamines and topical nasal steroids |
JP3098401B2 (en) | 1995-07-12 | 2000-10-16 | 株式会社エルティーティー研究所 | Formulation for nasal administration |
JP2791317B2 (en) | 1995-12-26 | 1998-08-27 | 株式会社三和化学研究所 | Multilayer film preparation |
DK0943326T4 (en) | 1996-02-27 | 2007-01-22 | Teijin Ltd | Powdery preparation for nasal administration |
JPH09253220A (en) | 1996-03-26 | 1997-09-30 | Kaajiopeeshingu Res Lab:Kk | Lead implantable in vivo |
US5976573A (en) * | 1996-07-03 | 1999-11-02 | Rorer Pharmaceutical Products Inc. | Aqueous-based pharmaceutical composition |
RU2111829C1 (en) | 1996-10-09 | 1998-05-27 | Буркин Сергей Павлович | Process of continuous manufacture of thin metal strip and machine for its realization |
US5955097A (en) | 1996-10-18 | 1999-09-21 | Virotex Corporation | Pharmaceutical preparation applicable to mucosal surfaces and body tissues |
TW503113B (en) | 1997-01-16 | 2002-09-21 | Senju Pharma Co | Aqueous suspension for nasal administration |
JP4009355B2 (en) | 1997-10-02 | 2007-11-14 | 村樫石灰工業株式会社 | Composition and method for controlling moss and algae occurring in turfgrass |
-
1999
- 1999-04-20 TW TW088106305A patent/TWI243687B/en active
- 1999-04-21 CA CA002294457A patent/CA2294457C/en not_active Expired - Lifetime
- 1999-04-21 JP JP55279399A patent/JP5142420B2/en not_active Expired - Lifetime
- 1999-04-21 UA UA2000010301A patent/UA77640C2/en unknown
- 1999-04-21 HU HU0002512A patent/HU226712B1/en unknown
- 1999-04-21 BR BRPI9906372A patent/BRPI9906372B8/en not_active IP Right Cessation
- 1999-04-21 EP EP99917086A patent/EP0998916B1/en not_active Expired - Lifetime
- 1999-04-21 CZ CZ0460499A patent/CZ298466B6/en not_active IP Right Cessation
- 1999-04-21 ID IDW991640A patent/ID24818A/en unknown
- 1999-04-21 PT PT99917086T patent/PT998916E/en unknown
- 1999-04-21 KR KR1019997012103A patent/KR100686901B1/en not_active IP Right Cessation
- 1999-04-21 WO PCT/JP1999/002126 patent/WO1999053899A1/en active IP Right Grant
- 1999-04-21 DK DK99917086T patent/DK0998916T3/en active
- 1999-04-21 GE GEAP19995184A patent/GEP20022669B/en unknown
- 1999-04-21 AU AU35343/99A patent/AU757772B2/en not_active Expired
- 1999-04-21 TR TR1999/03193T patent/TR199903193T1/en unknown
- 1999-04-21 CN CNB998008850A patent/CN1304052C/en not_active Expired - Lifetime
- 1999-04-21 EE EEP199900589A patent/EE05072B1/en unknown
- 1999-04-21 SI SI9930931T patent/SI0998916T1/en unknown
- 1999-04-21 SK SK1823-99A patent/SK286101B6/en not_active IP Right Cessation
- 1999-04-21 EA EA200000060A patent/EA002967B1/en not_active IP Right Cessation
- 1999-04-21 DE DE69932905T patent/DE69932905T2/en not_active Expired - Lifetime
- 1999-04-21 AT AT99917086T patent/ATE336986T1/en active
- 1999-04-21 US US09/446,276 patent/US6939559B1/en not_active Expired - Lifetime
- 1999-04-21 PL PL337534A patent/PL197875B1/en unknown
- 1999-04-21 NZ NZ501950A patent/NZ501950A/en not_active IP Right Cessation
- 1999-04-21 ES ES99917086T patent/ES2272064T3/en not_active Expired - Lifetime
- 1999-09-21 IL IL13361499A patent/IL133614A/en not_active IP Right Cessation
- 1999-10-19 GT GT199900180A patent/GT199900180A/en unknown
- 1999-10-19 GT GT199900180AK patent/GT199900180AA/en unknown
- 1999-10-20 RS YUP-544/99A patent/RS49764B/en unknown
- 1999-12-15 BG BG104020A patent/BG64919B1/en unknown
- 1999-12-17 ZA ZA9907727A patent/ZA997727B/en unknown
- 1999-12-20 NO NO19996323A patent/NO328270B1/en not_active IP Right Cessation
- 1999-12-20 IS IS5312A patent/IS2453B/en unknown
- 1999-12-22 HR HR990402A patent/HRP990402C1/en not_active IP Right Cessation
-
2002
- 2002-07-24 US US10/201,303 patent/US7235247B2/en not_active Expired - Lifetime
-
2003
- 2003-12-25 JP JP2003430651A patent/JP2004099624A/en active Pending
-
2005
- 2005-04-11 US US11/102,760 patent/US20050181054A1/en not_active Abandoned
-
2006
- 2006-11-10 CY CY20061101626T patent/CY1105771T1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT199900180AA (en) | PHARMACEUTICAL COMPOSITION TO BE APPLIED TO MUCOSES. | |
PT936905E (en) | SOLUBLE WATER FILM OR WATER SOLUBLE LAYER WHICH HAVE IMMEDIATE MOLHABILITY FOR ORAL APPLICATION | |
ES2109832T3 (en) | DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITION, PREPARATION AND USE PROCEDURE | |
ES2176730T3 (en) | PREPARATION OF PERCUTANEOUS TAPE CONTAINING FENTANIL. | |
DE69027022D1 (en) | LIPID AUXILIARY SUBSTANCES AND LOCAL APPLICATION | |
BR0014878A (en) | Pharmaceutical composition containing cyclosonide for mucosal application | |
BR9913135A (en) | Oral formulation | |
ES2092559T3 (en) | PHARMACEUTICAL FORMULATION CONTAINING PENCICLOVIR. | |
ATE245974T1 (en) | PHARMACEUTICAL COMPOSITIONS INTENDED FOR THE ORAL ADMINISTRATION OF PHLOROGLUCINOL AND THE PRODUCTION THEREOF | |
SV1999000181A (en) | PHARMACEUTICAL COMPOSITION TO BE APPLIED TO THE MUCOUS REF. ER / CR-203.689 | |
AR019245A1 (en) | PHARMACEUTICAL COMPOSITION TO BE APPLIED TO MUCOSES | |
CR6122A (en) | PHARMACEUTICAL COMPOSITION TO BE APPLIED TO MUCOSES | |
IT1291895B1 (en) | FLUID PHARMACEUTICAL PREPARATION BASED ON NIMESULIDE FOR ORAL AND RHINOPHARYNGAL USE | |
ES2189639B1 (en) | AQUOUS COMPOSITION CONTAINING ACETILSALICILIC ACID. | |
ES2139525B1 (en) | USE OF DERIVATIVES OF THE WHEY AS CITOPROTECTORS AND SCARS. |